11/12/2024
3:57 PM | Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
1:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
3:18 PM | Recursion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
5:05 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
5:12 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
|
11/04/2024
3:16 PM | Kinnevik AB (0001766574) (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/04/2024
12:27 PM | Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
8:46 AM | BAILLIE GIFFORD & CO (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
10/31/2024
5:01 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
4:20 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
10/29/2024
3:35 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/28/2024
4:25 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2024
3:22 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/18/2024
9:59 AM | Recursion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/17/2024
4:27 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
4:15 PM | Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:42 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/10/2024
5:40 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
5:00 AM | Recursion Pharmaceuticals (Filer)
| Form DEFM14A | |
10/09/2024
3:23 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
3:19 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024
5:29 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
5:30 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:58 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
9:27 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
12:31 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
7:03 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
1:20 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
5:15 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/26/2024
3:14 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
4:48 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:27 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/17/2024
5:03 AM | Recursion Pharmaceuticals (Filer)
| Form PREM14A | |
09/12/2024
5:28 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:15 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
4:00 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
09/06/2024
3:57 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
4:25 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
10:43 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:24 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/04/2024
12:16 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
3:48 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
3:27 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
7:02 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/30/2024
3:26 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:53 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:49 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/27/2024
3:10 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:42 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:25 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:48 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:25 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
6:09 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
6:09 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
4:24 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:35 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:22 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:19 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/08/2024
4:23 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
11:56 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
7:05 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:09 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:10 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/07/2024
12:34 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
3:50 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
5:16 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
5:15 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
3:37 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:17 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
5:52 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4/A | |
07/12/2024
5:54 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:51 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
3:51 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2024
9:38 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:41 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
11:56 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:30 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:25 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2024
3:17 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
07/03/2024
3:39 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:39 PM | Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:39 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:40 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025!
Trump could trigger THIS crypto coin…
 YES, I WANT THE #1 CRYPTO NOW |
06/28/2024
4:14 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
6:13 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
4:09 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2024
12:04 PM | Recursion Pharmaceuticals (Filer)
| Form 424B5 | |
06/27/2024
7:16 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
3:01 PM | Recursion Pharmaceuticals (Filer)
| Form 424B5 | |
06/25/2024
3:21 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
7:02 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
4:46 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free RXRX Stock Alerts